Valuation: China Resources Double-Crane Pharmaceutical Co.,Ltd.

Market Cap 16.39B 2.45B 2.13B 2.01B 1.83B 3.43B 235B 3.44B 24.12B 9.31B 119B 9.19B 8.98B 384B P/E 2026 *
9.28x
P/E 2027 * 8.67x
Enterprise Value 16.39B 2.45B 2.13B 2.01B 1.83B 3.43B 235B 3.44B 24.12B 9.31B 119B 9.19B 8.98B 384B EV / Sales 2026 *
1.44x
EV / Sales 2027 * 1.37x
Free-Float
37.31%
Yield 2026 *
3.21%
Yield 2027 * 3.34%
1 day+0.44%
1 week-0.94%
Current month-1.31%
1 month-1.18%
3 months-4.68%
6 months-12.99%
Current year-13.23%
1 week 15.72
Extreme 15.72
16.09
1 month 15.57
Extreme 15.57
16.33
Current year 15.29
Extreme 15.29
19.08
1 year 15.29
Extreme 15.29
19.77
3 years 14.8
Extreme 14.8
26.15
5 years 11.25
Extreme 11.25
37.44
10 years 10.66
Extreme 10.66
37.44
Manager TitleAgeSince
Director of Finance/CFO 43 18/02/2025
President 45 25/10/2024
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 68 30/05/2006
Director/Board Member 67 12/07/2021
Director/Board Member 60 10/10/2022
Date Insider Type Main position Quantity % Market Cap. Importance
21/12/22 Buy

Chairman

5,000 0.0005%
21/12/22 Buy

Director

10,000 0.0010%
20/12/22 Buy

Director

5,000 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
+0.44%-0.94%-16.74%-2.94% 2.43B
-0.81%+2.54%+49.95%+100.25% 1,027B
-0.11%+1.63%+54.97%+66.12% 651B
+0.03%+2.76%+19.03%+71.64% 467B
-1.22%+3.66%+36.44%+38.32% 350B
-0.79%+2.73%+19.03%+25.08% 268B
+0.58%+6.76%+11.13%+16.52% 257B
+0.77%+1.49%+38.80%+45.49% 205B
+0.79%+1.84%-28.27%-56.71% 190B
-0.24%+4.75%+32.49%+99.07% 187B
Average -0.11%+2.13%+21.68%+40.29% 360.45B
Weighted average by Cap. -0.36%+2.62%+34.77%+61.30%

Financials

2026 *2027 *
Net sales 11.39B 1.7B 1.48B 1.4B 1.27B 2.38B 163B 2.39B 16.77B 6.47B 82.93B 6.39B 6.24B 267B 11.98B 1.79B 1.56B 1.47B 1.34B 2.5B 171B 2.51B 17.63B 6.8B 87.18B 6.71B 6.56B 281B
Net income 1.78B 265M 231M 218M 198M 371M 25.43B 373M 2.61B 1.01B 12.93B 995M 973M 41.6B 1.9B 284M 247M 233M 212M 397M 27.2B 399M 2.8B 1.08B 13.83B 1.06B 1.04B 44.5B
Net Debt - -
Logo China Resources Double-Crane Pharmaceutical Co.,Ltd.
China Resources Double-Crane Pharmaceutical Co Ltd is a China-based company primarily engaged in the new drug research and development, preparation production, drug sales, and active pharmaceutical ingredients (API) production. The Company operates two segments. The Infusion segment is mainly engaged in the production and sale of infusion products and the provision of services. The Non-Infusion segment is mainly engaged in the production and sale of non-infusion products and the provision of services. The Company's chronic disease business products include compound reserpine triamterene tablets, gliquidone tablets and others. The Company's specialty business products include teniposide injection, busulfan injection and others. The Company's infusion business products include basic infusion, therapeutic infusion, nutritional infusion and other multi-category infusion products. The Company's API business products include valsartan, amlodipine, pregabalin and others.
Employees
13,184
Date Price Change Volume
18/09/26 CN¥15.87 +0.44% 4,507,110
17/09/26 CN¥15.80 -0.06% 3,142,455
16/09/26 CN¥15.81 -1.06% 5,295,995
15/09/26 CN¥15.98 -0.44% 3,710,100
14/09/26 CN¥16.05 +1.39% 3,959,700
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
15.87CNY
Average target price
24.30CNY
Spread / Average Target
+53.12%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600062 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!